ArticleRadiology case reports2024

Ipilimumab and nivolumab plus radioembolization as salvage therapy for atezolizumab and bevacizumab refractory hepatocellular carcinoma resulting in complete pathologic response.

Claudia R Silver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.